NovoCure Ltd (NVCR) earnings date
Feb 25, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 67% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 30 days, typically, give or take 14 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Oct 29, 2026 | before open | 29 | 8-K |
| Q2 FY2026 | Thu, Jul 23, 2026 | before open | 23 | 8-K |
| Q1 FY2026 | Thu, Apr 30, 2026 | before open | 30 | 8-K |
| Q4 FY2025 | Thu, Feb 26, 2026 | before open | 57 | 8-K |
| Q3 FY2025 | Thu, Oct 30, 2025 | before open | 30 | 8-K |
| Q2 FY2025 | Thu, Jul 24, 2025 | before open | 24 | 8-K |
| Q1 FY2025 | Thu, Apr 24, 2025 | before open | 24 | 8-K |
| Q4 FY2024 | Thu, Feb 27, 2025 | before open | 58 | 8-K |
What they guided beta
| Q3 FY2026 | "Document Novocure Reports Third Quarter 2026 Financial Results and Raises 2026 Guidance Third quarter net revenues of $193 million an increase of 16% year-over-year, driven by 19% growth in active patients worldwide Strong performance drove increased net revenue guidance for full-year 2026 to $736 million - $743 million and adjusted EBITDA guidance to $24 million - $34 million Optune Pax® approved by Japan's Ministry of Health, Labour and Welfare for the treatment of locally advanced pancreatic cancer BAAR, Switzerland – October 29, 2026 - Novocure (Nasdaq: NVCR) today reported financial resul" exhibit |
| Q3 FY2026 | "Based on the results from this quarter, we have raised our financial guidance for 2026 and will continue to build on the strong progress we have made on our path to profitability.”" exhibit |
| Q3 FY2026 | "Guidance: Novocure’s updated guidance for the full year 2026, as of October 29, 2026, is summarized below:" exhibit |
| Q3 FY2026 | "Adjusted EBITDA*: $24 million - $34 million (previous: $0 million - $15 million) This guidance assumes full-year mid-to-high single digit net revenue growth from Optune Gio, net revenue contribution from Optune Lua and Optune Pax, collectively, between $30 million and $34 million, foreign exchange rates as of September 30, 2026, and quarterly gross margin in the mid-to-high 70s percent." exhibit |
| Q2 FY2026 | "Optune Pax received CE (Conformité Européenne) Mark for the treatment of adult patients with locally advanced pancreatic cancer of exocrine origin, concomitant with gemcitabine and nab-paclitaxel (gem/nab-pac) in accordance with guideline recommendations. 2026 financial guidance: Novocure’s updated guidance for the full year 2026, as of July 23, 2026, is summarized below:" exhibit |
| Q2 FY2026 | "Adjusted EBITDA*: $0 million - $15 million (previous: $(15) million - $0 million) This guidance assumes full-year mid-to-high single digit net revenue growth from Optune Gio, foreign exchange rates as of June 30, 2026 and consistent quarterly gross margin in the mid-70s percent." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/NVCR
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/NVCR
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/NVCR/"><img src="https://veritasdata.dev/embed/NVCR.svg" alt="NVCR earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/NVCR/)
Script
<script async src="https://veritasdata.dev/embed/NVCR.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/NVCR"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.